Belrose, Australia, April 15th 2013 – Varian Medical Systems has become the first oncology systems company to become a licensee of the Medical Technology Industry’s Code of Practice, as administered by the Medical Technology Association of Australia (MTAA). In addition, all Varian Medical Systems employees in Australia have successfully undertaken the MTAA Code of Conduct training.
“We are honoured to become a code licensee for an organization which is committed to enhancing treatments and outcomes for patients in Australia,” says Chris Cowley, managing director of Varian Medical Systems Australasia. “As a code licensee, Varian makes a commitment to adhere to the principles and requirements of the Code and support ethical business practice in radiation oncology.”
The Medical Technology Association of Australia (MTAA) is the national association representing companies in the medical technology industry. MTAA aims to ensure the benefits of modern, innovative and reliable medical technology are delivered effectively to provide better health outcomes to the Australian community.
“I congratulate Varian on obtaining the code license and so publically reaffirming their support of ethical business practices when working with healthcare professionals and consumers,” said MTAA Chief Executive Officer Anne Trimmer.
Varian radiation therapy equipment is installed in dozens of hospitals and clinics in Australia and New Zealand, including Royal Prince Alfred (NSW), Royal North Shore (NSW), Westmead (NSW), Peter MacCallum Cancer Centre (VIC), Geelong (VIC), Epworth Group (VIC), Sir Charles Gairdner (WA), Royal Adelaide (SA), Premion group (QLD), ROQ Group (QLD), GenesisCare and all public radiotherapy centres in New Zealand and Tasmania. Varian Medical Systems Australasia employs more than 60 people and is headquartered in Belrose, New South Wales.
Varian Medical Systems is the world leader in radiotherapy and radiosurgery for treating cancer and other conditions. The inventor of linear accelerator technology for delivering radiotherapy treatments, Varian has pioneered ongoing advances in treatment precision such as intensity modulated radiotherapy, image-guided radiotherapy, stereotactic radiosurgery and RapidArc® volumetric treatments.
Editorial contacts: Catherine McClintock, Varian Medical Systems Australia, 61.2.9485.0111, Neil Madle, Investor Relations Director, Europe +44 7786 526068
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing workstations for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications. Varian Medical Systems employs approximately 6,200 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.